Member Info for Vinylspinner

Fantastic news!!

C’mon Solvonis let’s put the ‘Ket’ amongst the pigeons and grow baby grow!

Brilliant bit of business!

*risk not desk 😂

Jeez, too excited with the deal completion

Great to see this deal get over the line.

Solvonis can now focus completely on delivery as, the Awaken deal would have taken a lot of ‘bandwidth’ over the last 6 months.

Now fully incorporated I expect and anticipate more focused shareholder PR and increased news flow.

Exciting times ahead.

I’ll be using some dry powder to add to my holding now the risk of desk getting over the line has been removed.

Well done to the BOD.

I’m of the same opinion. It’s been a grind holding on, but once all the i’s & t’s are crossed, I’m expecting greatness here. Very long & strong for this minnow.

Captain AI Joe!

This share has Albatross wings! Fly baby fly!

Great to see positive progress on the Patent application.

Step by step

Block by block

Strong foundations are the key.

Well done to the team at Solvonis.

Tricky Blue ball, coming to a F & B stand near you.

Great to see some buyers today. Q2 just on the horizon.

Top team

Awaken deal

Advanced trials in a multi billion pound market for an unmet need, helping people.

Measly Mcap for the potential here.

The penny will literally drop one day and all holders patience will be rewarded for there conviction.

I look forward to a LSE SVNS holders 8p meet up.

Nice update, highlighting all the work going on and strong news flow expected throughout 2025.

The network our team has will allow us to open many doors.

Great update for this new company and direction on the roadmap is clearly focused on success.

Np Tricky.

Long & Strong 💪🏻

I’m very confident, albeit frustrated to see us still down here on paper, but I’ll keep adding monthly and when the awaken deal goes through(2nd qtr 2025) I’m sure all the foundational work in the background will begin to gain traction, news flow will increase and when the herd arrive we’ll look back and say, why didn’t we add more.

Glah.

Hey Sam,

I’d say it was a buy.

I was looking at buying 250,000 earlier and buy price was 0.16.

I ended up paying 0.1625 when I bought in later just before the close.

Nice to the red dot m/c is working again.

Still holding long & strong in the wings.

Excited to be a shareholder from the start of this journey.

Hello to all you fellow holders out there 👋🏻

The team is just getting stronger and stronger.

Glah.

General population

• Trauma Survivors:

• Natural Disaster Survivors: Individuals recovering from hurricanes, earthquakes, or other disasters.

• Accident Victims: Car crashes and workplace accidents contribute significantly to PTSD cases.

• Victims of Violence: Those who experience domestic abuse, sexual assault, or other violent crimes.

• Childhood Trauma Survivors: An estimated 4-6% of the general population has PTSD related to adverse childhood experiences.

First Responders

• Police Officers: PTSD prevalence is estimated at 7-19% among law enforcement professionals.

• Firefighters: Around 17-22% of firefighters experience PTSD due to exposure to trauma during emergencies.

• Emergency Medical Technicians (EMTs): EMTs face frequent traumatic situations, with PTSD prevalence estimated at 20%.

Military & Veterans

• Veterans: According to U.S. Department of Veterans Affairs data, around 11-20% of veterans from recent conflicts (e.g., Iraq and Afghanistan) experience PTSD annually.

• Active Military Personnel: Roughly 7-8% of all service members may develop PTSD during their careers.

• Families of Military Personnel: Secondary benefits would extend to families impacted by a loved one’s PTSD.

Healthcare & Mental services

Psychiatrists, Psychologists, and Therapists: Professionals providing therapy for PTSD could integrate the treatment into their practices.

• Primary Care Physicians: They would see fewer cases of untreated PTSD leading to comorbid conditions like cardiovascular issues or substance abuse.

• Veterans Affairs (VA) Clinics: With PTSD affecting a significant portion of military veterans, particularly those returning from combat, this sector would see a transformative impact.

Now fixed on Solvonis Therapeutics Plc

Yes Tricky, I know I am!! 😌

The potential here is off the scale.

Sub £5 mil Mcap for what we have here is, and let’s be honest here quite simply ridiculous.

X that by 10 and I’d still feel super comfy given the global potential of these therapeutics, and the currently unmet need medical for these disorders.

A very happy vinyl spinner this morning and so happy to be a holder here.

Morning Tricky.

Indeed, indeed, total validation in the “new company”

Game changing news imo.

Should get interviews galore, and they have something tangible to discuss, negotiate with future partners to accelerate the programme.

Game on, let’s go!

Professor David Nutt, Senior Scientific Advisor to Graft Polymer (UK) Plc, commented: "These findings represent an important milestone for our aminoindane programme. Developing compounds that combine therapeutic efficacy with improved safety has transformative potential for treating PTSD and other trauma-related conditions."

Anthony Tennyson, CEO of Graft Polymer (UK) Plc, added: "We are greatly encouraged by these initial results in our aminoindane NCE programme. AW21003's ability to enhance pro-social behaviours while demonstrating a favourable safety profile highlights its potential to address critical unmet needs in PTSD treatment. Through continued collaboration with Awakn and our academic and industry partners, we remain dedicated to creating innovative therapies that significantly improve the lives of individuals living with trauma-related mental health disorders."

Wonderful. Incredible initial results.

Excellent initial test data announced in todays RNS.

We’re on our way!! Congratulations to Graft, & there partners.

Let’s burn fence 22 today and crack that whip(ethically of course) 😌